Cefdinir labels and packages: Difference between revisions

Latest revision as of 00:55, 6 January 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Adapted from the FDA Package Insert.

@@ Line 1: / Line 1: @@
 __NOTOC__
 {{Cefdinir}}
-{{CMG}}
+{{CMG}}; {{AE}} {{SS}}
+==Labels and Packages==
 {|
 |-
-|[[File:Cefdinir 14.jpg|thumb|400px|left]]
+|[[File:Cefdinir 14.jpg|thumb|800px|left]]
 |-
-|}<ref>{{Cite web | last = |first = |title = http://www.accessdata.fda.gov/drugsatfda_docs/label/1999/50739S2LBL.pdf |url =http://www.accessdata.fda.gov/drugsatfda_docs/label/1999/50739S2LBL.pdf |publisher = |date = | accessdate = }}</ref>
+|}
-==References==
-{{Reflist}}
 {{FDA}}